Assignee
SHUTTLE PHARMACEUTICALS INC
US·8 granted patents·5 pending applications·0 citations·filing 2016–2025
Top patents by PatentIndex Score
13 records- 0183US12357650B2Methods and compositions for cancer therapies that include delivery of halogenated thymidines and thymidine phosphorlylase inhibitors in combination with radiationSHUTTLE PHARMACEUTICALS INC·Filed 2023·Granted Jul 15, 2025·0 cites·14 claims
- 0278US2025302857A1Methods And Compositions For Cancer Therapies That Include Delivery Of Halogenated Thymidines And Thymidine Phosphorylase Inhibitors In Combination With RadiationSHUTTLE PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 0377US2023302034A1Methods And Compositions For Cancer Therapies That Include Delivery Of Halogenated Thymidines And Thymidine Phosphorylase Inhibitors In Combination With RadiationSHUTTLE PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0475US12077515B2Selective histone deacetylase inhibitors for the treatment of human diseaseSHUTTLE PHARMACEUTICALS INC·Filed 2022·Granted Sep 3, 2024·0 cites·20 claims
- 0574US2022055988A1Dual function molecules for histone deacetylase inhibition and ataxia telangiectasia mutated activation and methods of use thereofSHUTTLE PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 0669US2020317611A1Dual function molecules for histone deacetylase inhibition and ataxia telangiectasia mutated activation and methods of use thereofSHUTTLE PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 0769US2024174630A1Selective histone deacetylase inhibitors for the treatment of human diseaseSHUTTLE PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0868US10730834B2Dual function molecules for histone deacetylase inhibition and ataxia telangiectasia mutated activation and methods of use thereofSHUTTLE PHARMACEUTICALS INC·Filed 2017·Granted Aug 4, 2020·0 cites·10 claims
- 0967US11654157B2Methods and compositions for cancer therapies that include delivery of halogenated thymidines and thymidine phosphorylase inhibitors in combination with radiationSHUTTLE PHARMACEUTICALS INC·Filed 2018·Granted May 23, 2023·0 cites·10 claims
- 1065US11407723B2Selective histone deacetylase inhibitors for the treatment of human diseaseSHUTTLE PHARMACEUTICALS INC·Filed 2019·Granted Aug 9, 2022·0 cites·5 claims
- 1164US11584733B2Selective histone deacetylase inhibitors for the treatment of human diseaseSHUTTLE PHARMACEUTICALS INC·Filed 2021·Granted Feb 21, 2023·0 cites·20 claims
- 1263US10745352B2Dual function molecules for histone deacetylase inhibition and ataxia telangiectasia mutated activation and methods of use thereofSHUTTLE PHARMACEUTICALS INC·Filed 2016·Granted Aug 18, 2020·0 cites·4 claims
- 1348US11034667B2Selective histone deacetylase inhibitors for the treatment of human diseaseSHUTTLE PHARMACEUTICALS INC·Filed 2018·Granted Jun 15, 2021·0 cites·6 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →